Some patients benefit from longer-term GLP-1 therapy, especially those with diabetes, severe insulin resistance, or ongoing metabolic disease
It is to be determined whether Eli Lilly, Mounjaro, and other manufacturers will be included in the lawsuit
At Klinic, we work with major insurers like United Healthcare, Blue Cross Blue Shield, Aetna, Cigna, Humana Medicare, Amerigroup, CareSource, and others to ensure your access to this vital medication
With proactive management, many patients can continue achieving meaningful metabolic benefits beyond the initial treatment phase
nevertheless, their unique TCR structure, antigen recognition mode (CD1d-dependent), and functional characteristics classify them as an independent innate-like lymphocyte subset (103)